Advantages of Panx1 as a drug target are that it is accessible to drugs and Panx1 inhibitors are already available and FDA approved, such as the anti-malaria drug mefloquine and the gouty arthritis drug probenecid. Here, PANX1 is linked to arthritic joint disease.